| Jade Hannah Evans, MS | |
|
1001 Sycamore Ln, Danville, IN 46122-1474 | |
| (317) 501-6912 | |
| Not Available |
| Full Name | Jade Hannah Evans |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1001 Sycamore Ln, Danville, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538895842 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jade Hannah Evans, MS 1001 Sycamore Ln, Danville, IN 46122-1474 Ph: () - | Jade Hannah Evans, MS 1001 Sycamore Ln, Danville, IN 46122-1474 Ph: (317) 501-6912 |
News Archive
METTLER TOLEDO's brand-new MultiMountTM weigh modules are helping manufacturers in food, pharma and other industries obtain the hygiene, convenience and accuracy required to keep them ahead of the pack.
Semafore Pharmaceuticals today announced the presentation of data demonstrating that SF1126, a novel small molecule inhibitor of phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR), has broad preclinical anti-tumor activity in multiple myeloma and lymphoma. Data were presented in a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting in Washington, D.C.
A new study suggests that less than 10% of the estimated 3,591 adults in the UK with the genetic condition congenital adrenal hyperplasia (CAH) receive specialist endocrine care, and that there is no standard treatment for these patients.
Bioengineers at the University of California, San Diego and GlySens Incorporated have developed an implantable glucose sensor and wireless telemetry system that continuously monitors tissue glucose and transmits the information to an external receiver. The paper, published in the July 28, 2010 issue of the journal Science Translational Medicine, describes the use of this glucose-sensing device as an implant in animals for over one year. After human clinical trials and FDA approval, the device may be useful to people with diabetes as an alternative to finger sticking and short-term, needle-like glucose sensors that have to be replaced every three to seven days.
› Verified 4 days ago
Mrs. Hillary N Rudolphi, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3380 E Main St, Danville, IN 46122 Phone: 317-718-0089 | |
Alison Marshall Winters, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1001 Sycamore Ln, Danville, IN 46122 Phone: 317-745-7503 | |
Tammy Navarro, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Main St, Danville, IN 46122 Phone: 317-745-3414 | |
Sarah Wanger, M.S., CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3380 E Main St, Danville, IN 46122 Phone: 317-718-0089 Fax: 317-718-0097 | |
Ms. Jennifer Laine Hagemeyer, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1001 Sycamore Ln, Danville, IN 46122 Phone: 317-745-4715 | |
Mrs. Teresa A Nering, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1001 Sycamore Ln, Danville, IN 46122 Phone: 317-745-7066 | |
Michelle Jordan, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1001 Sycamore Ln, Danville, IN 46122 Phone: 317-745-4715 Fax: 317-745-8271 |